Clinical Features and Experience in the Treatment of Penile Cancer in San Juan de Dios Hospital in Guatemala
DOI:
https://doi.org/10.54212/27068048.v9i2.3Keywords:
penile cancer, total penectomy, partial penectomyAbstract
AIM: To present the clinical characteristics of the patients as well as the experience in the management of patients diagnosed with penile cancer during the year 2021 at the San Juan de Dios General Hospital in Guatemala. MATERIAL AND METHOD: A search was made for cases of penile cancer during the year 2021 at the San Juan de Dios General Hospital, only cases with histopathological diagnosis and complete file were included. RESULTS: In the year 2021, 5 patients with penile cancer between 45 and 76 years of age were found. Overall, the following risk factors were identified: phimosis, chronic penile inflammation, rural origin, low socioeconomic status, single, multiple partners. Three patients were treated by total penectomy with perineal urethrostomy and two by partial penectomy. Superficial and deep inguinal lymphadenectomy was performed on four patients. Patients with two or more positive nodes received adjuvant chemotherapy. Among the complications observed by lymphadenectomy were lymphorrhea, lymphedema and necrosis at the edges of the wounds. CONCLUSIONS: Penile cancer is a rare disease, identifying and modifying risk factors make it preventable for most. The most important prognostic factor for penile cancer survival is regional lymph node status, so treatment with inguinal lymphadenectomy for intermediate- and high-risk patients is crucial. Inguinal lymphadenectomy is not without complications; however, the benefits of such procedures outweigh the risks.
Downloads
References
B. Hakenberg OW, Dräger DL, Erbersdobler A, Naumann CM, Jünemann KP, Protzel C: The diagnosis and treatment of penile cancer. Dtsch Arztebl Int 2018; 115: 646-52. https://doi.org/10.3238/arztebl.2018.0646 DOI: https://doi.org/10.3238/arztebl.2018.0646
D. Joren Vanthoor, Gigi Vos, Maarten Albersen: Penile cancer: potential target for immunotherapy?, Springer-Verlag GmbH Germany, part of Springer Nature 2020. https://doi.org/10.1007/s00345-020-03510-7 DOI: https://doi.org/10.1007/s00345-020-03510-7
G. Jad Chahoud, MD, MPH; Manish Kohli, MD; and Philippe E. Spiess, MD, MS: Management of Advanced Penile Cancer, Mayo Foundation for Medical Education and Research, Mayo Clin Proc. 2020;nn(n):1-13, https://doi.org/10.1016/j.mayocp.2020.06.031 DOI: https://doi.org/10.1016/j.mayocp.2020.06.031
European Association of Urology guidelines on penile cancer (2021).
National Comprehensive Cancer Network (NCCN) Guidelines on penile cancer, versión 2.2022 (2022).
A. Michele Marchioni, Francesco Berardinelli, Cosimo de Nunzio, Philippe Spiess, Francesco Porpiglia, Luigi schips, Luca cindolo: New insight in penile cancer, Minerva Urologica e Nefrologica 2018 December;70(6):559-69 https://doi.org/10.23736/S0393-2249.18.03215-0 DOI: https://doi.org/10.23736/S0393-2249.18.03215-0
C. James Ferguson & Andrew Fang (2020): Penile sparing techniques for penile cancer, Postgraduate Medicine, https://doi.org/10.1080/00325481.2020.1822052 DOI: https://doi.org/10.1080/00325481.2020.1822052
E. Cubilla AL, Velazquez EF, Amin MB, et al. The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations. Histopathology. 2018; 72(6): 893-904, https://doi.org/10.1111/his.13429 DOI: https://doi.org/10.1111/his.13429
F. George Coba & Trushar Pate; Penile Cancer: Managing Sexual Dysfunction and Improving Quality of Life After Therapy, https://doi.org/10.1007/s11934-020-01022-w DOI: https://doi.org/10.1007/s11934-020-01022-w
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Oliver Armando Tzul Agust´ín, Juan Pablo Lezana Vega, Víctor Hernández Castellanos y Braulio Francisco Reyes Méndez
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
